ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

STAA STAAR Surgical Company

21.95
0.00 (0.00%)
Pre Market
Last Updated: 09:09:33
Delayed by 15 minutes
Share Name Share Symbol Market Type
STAAR Surgical Company NASDAQ:STAA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 21.95 21.95 25.73 0 09:09:33

STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)

13/11/2024 12:00pm

Business Wire


STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart


From Nov 2024 to Feb 2025

Click Here for more STAAR Surgical Charts.

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with STAAR Management at the upcoming Stephens Annual Investment Conference, which will be held in Nashville, TN.

Event: Stephens Annual Investment Conference (NASH2024) Management Attendee: Patrick F. Williams, Chief Financial Officer Date: Wednesday, November 20, 2024 Time: 11:00 a.m. ET / 8:00 a.m. PT Location: Live Webcast

The live webcast link includes an option to pre-register. An online replay of the webcast will also be available on STAAR’s investor website at https://investors.staar.com/.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL,” which includes the EVO ICL™ product line. More than 3,000,000 ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more information, please visit the Company’s website at www.staar.com.

Investors & Media Brian Moore Vice President, Investor Relations and Corporate Development (626) 303-7902, Ext. 3023 bmoore@staar.com

Connie Johnson Director, Investor Relations and HPMS (626) 303-7902, Ext. 2207 cjohnson@staar.com

1 Year STAAR Surgical Chart

1 Year STAAR Surgical Chart

1 Month STAAR Surgical Chart

1 Month STAAR Surgical Chart

Your Recent History

Delayed Upgrade Clock